Skip to main content
. 2018 Nov 23;15(14):1746–1756. doi: 10.7150/ijms.28440

Figure 3.

Figure 3

Overall survival and disease-free survival rates of HCC patients with differential CK and SALL4 expression as estimated by the Kaplan-Meier method and the log-rank test. The overall survival rate in HCC patients with CK7 expression was less than patients without CK7 expression (25.1 months vs. 37.0 months, p =0.933)(A); with CK19 expression was less than patients without CK19 expression (22.4 months vs. 61.3 months, p =0.028)(B); with normal CK8 expression was less than patients with decreased CK8 expression (27.0 months vs. 38.0 months, p =0.692)(C); with normal CK18 expression was less than the patients with decreased CK18 expression (27.0 months vs. 38.0 months, p =0.442)(D); with SALL4 expression was greater than the patients without SALL4 expression (38.0 months vs. 35.3 months, p =0.999)(E). The disease-free survival rate in HCC patients with CK7 expression was less than the patients without CK7 expression (13.6 months vs. 25.1 months, p =0.784)(F); with CK19 expression was less than patients without CK19 expression (8.7 months vs. 39.0 months, p =0.001)(G); with normal CK8 expression was less than the patients with decreased CK8 expression (18.8 months vs. 20.4 months, p =0.930)(H); with normal CK18 expression was less than the patients with decreased CK18 expression (18.8 months vs. 20.4 months, p =0.854)(I); with SALL4 expression was less than the patients without SALL4 expression (11.7 months vs. 18.8 months, p =0.815)(J).